Nitric Oxide-Mediated Minimally Invasive Neuromodulation through Gut-Brain Axis via a Bioelectronic Microdevice for Relieving Depressive Symptoms.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42373321.
- Also identified by DOI 10.1021/acsnano.6c03685.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Minimally invasive brain modulation is essential for understanding and treating neurological disorders. This study presents a wireless, optically controlled nitric oxide (NO)-releasing microbioelectronic device (ONMD) that enables peripheral-to-central neuromodulation without direct brain intervention. Upon light activation, the ONMD releases NO to locally activate transient receptor potential (TRP) channels, forming a confined NO-TRP signaling hub that selectively stimulates the vagus nerve and activates the nucleus tractus solitarius (NTS), a key brainstem center involved in autonomic and reward regulation. Through this hierarchical pathway, the ONMD-mediated neuromodulation alleviates depressive-like behaviors in mice, accompanied by reduced peripheral inflammation and restored central serotonin (5-HT) homeostasis. Operating in the intestine, the ONMD achieves remote modulation of central circuits through peripheral access. This gasotransmitter-mediated, multilevel bioelectronic approach offers a noninvasive strategy for regulating brain function and advancing neuropsychiatric therapies.